PBMCs: buying pbmcs, what to settle before you buy pbmcs or human pbmcs, what to ask before you buy human pbmc material, how pbmc cells differ from other human primary cells, and the consent and donor documentation a shipment must arrive with
Peripheral blood mononuclear cells are bought from a supplier rather than made, and what you are really buying is a documentation chain: consented collection, a characterised donor, a validated isolation and a cold chain that did not break. The cells either work in your assay or they do not, and the difference is usually upstream of anything you can see in the vial. This page covers what to specify and what evidence to require before a purchase order goes out.
- the Common Rule governing research with human subjects, 45 CFR
- Part 46
- the FDA rule covering human cells, tissues and cellular products
- Part 1271
- the OSHA bloodborne pathogens standard for handling human material
- 1910.1030
Figures in this panel are the rules that govern buying and handling human primary cells, named from the regulations themselves and linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a biospecimen price index it has not measured.
- 4 vendor service pages verifiedevery figure matched verbatim to the vendor's page
- Quoted and dated, never estimatedlast verification pass 2026-08-24
- 1 service classes coveredeach with measured search demand behind it
What to specify and what to demand
- Fresh or cryopreserved. Fresh cells ship within a short window and give the most physiological response, at the cost of scheduling your experiment around a collection. Cryopreserved vials are available on demand and from a characterised lot you can return to, at the cost of viability and of a recovery step that has to be validated for your assay.
- Donor characterisation. Decide which donor attributes your question actually depends on: serology status, HLA type, smoking, medication, disease state, age band and sex are all available at a price. Specifying attributes you do not need narrows the donor pool and raises the cost without improving the experiment.
- The consent chain. Ask for evidence that collection was under an approved protocol with informed consent covering the research use you intend, including commercial use if that is where the work goes. A supplier that cannot evidence this is a supplier whose material may not be usable in a publication or a filing.
- Lot reservation and repeatability. If the study runs over months, reserve the lot. A comparison across donors is a different experiment from a comparison across time on one donor, and discovering mid-study that the lot is exhausted forces the first when you designed the second.
- Cold chain and acceptance. Require a temperature record with the shipment and define acceptance criteria before it arrives: viability on thaw, recovery, and the assay-relevant functional check. Agree in writing what happens when a shipment fails them, because that conversation is much harder afterwards.
Why two suppliers' cells behave differently
Isolation method, time from draw to freeze, freezing medium, cooling rate and the number of handling steps all move recovery and function, and suppliers differ on every one of them. Two vials with the same label and the same nominal count can give different results in the same assay, which is why a supplier change is a protocol change and should be bridged rather than assumed.
Ask for the isolation and cryopreservation method in writing. Suppliers that treat it as proprietary are asking you to accept an uncontrolled variable in your own experiment.
Leukopaks and larger formats
Where an experiment needs large numbers from one donor, a leukopak is normally cheaper and more consistent than many vials, and it lets you isolate and freeze on your own terms. The trade is that you take on the isolation, the validation and the storage.
For a lab running one or two experiments a year, buying isolated cells is almost always the better deal. For a lab running a programme, in-house isolation from a fresh collection pays back quickly and removes a supplier from the critical path.
Common questions
- What are PBMCs?
- Peripheral blood mononuclear cells: the lymphocyte and monocyte fraction isolated from blood by density gradient. They are the standard starting material for immunology, immuno-oncology and vaccine response work.
- Fresh or cryopreserved PBMCs?
- Fresh gives the most physiological response and requires scheduling around a collection. Cryopreserved is available on demand from a repeatable lot and needs a validated thaw and rest step. Most programmes use cryopreserved and bridge to fresh where function is in question.
- What documentation should a PBMC supplier provide?
- Evidence of consented collection under an approved protocol covering your intended use, donor characterisation to the attributes you specified, infectious disease testing results, the isolation and cryopreservation method, and a lot certificate with viability and count.
- Can I use purchased PBMCs for commercial research?
- Only if the donor consent and the supplier's terms cover commercial use. This is a common and expensive thing to discover late, so confirm it in writing before the first purchase rather than at publication or filing.
Get a shortlist for your project
Browse by service class
Sources
Cite or embed this figure
The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.
Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/pbmc/.